Sage Journals: Discover world-class research

Abstract

The last session of the 2025 Second Joint Congress of the British Society of Toxicological Pathology (BSTP) and the European Society of Toxicologic Pathology (ESTP) held in Manchester (United Kingdom) reviewed current recommendations and best practices for carcinogenicity risk assessment. The session comprised an introductory lecture about new approaches for screening for carcinogenicity, a joint session presenting a regulatory perspective about the Weight of Evidence (WoE) assessment for agrochemicals and pharmaceuticals, followed by another joint session elaborating on the industry experience about WoE. In addition, 3 case examples were presented to illustrate the challenges of in vivo carcinogenicity assessment in rodents within the current paradigm.

Keywords

carcinogenicity weight of evidence rodents alternative approaches regulatory pharmaceuticals agrochemicals

Get full access to this article

View all access options for this article.

References

European Commission. Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market Text with EEA relevance. Published 2013. Accessed November 17, 2025. https://eur-lex.europa.eu/eli/reg/2013/283/oj/eng.

European Commission. Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. Published 2009. Accessed November 17, 2025. https://eur-lex.europa.eu/eli/reg/2009/1107/oj/eng.

European Medicines Agency. ICH guideline S1B(R1) on testing for carcinogenicity of pharmaceuticals Step 5. Published 2022. Accessed November 17, 2025. https://www.ema.europa.eu/en/ich-guideline-s1br1-testing-carcinogenicity-pharmaceuticals-scientific-guideline.

European Medicines Agency. ICH topic S1A the need for carcinogenicity studies of pharmaceuticals Step 5. Published 1996. Accessed November 17, 2025. https://www.ema.europa.eu/en/ich-s1a-need-carcinogenicity-studies-pharmaceuticals-scientific-guideline.

Hilton

Adcock

Akerman

, et al. Rethinking chronic toxicity and carcinogenicity assessment for agrochemicals project (ReCAAP): a reporting framework to support a weight of evidence safety assessment without long-term rodent bioassays. Regul Toxicol Pharmacol. 2022;131:105160.

OECD. Developing Integrated Approaches for Testing and Assessment (IATAs) in order to support chemical safety. Published 2022. Accessed November 17, 2025. https://www.oecd.org/en/topics/sub-issues/assessment-of-chemicals/integrated-approaches-to-testing-and-assessment.html.

OECD. Test No. 451: Carcinogenicity Studies, OECD Guidelines for the Testing of Chemicals, Section 4. Paris: OECD Publishing; 2018.

OSHA. Regulation (EC) No 1272/2008—classification, labelling and packaging of substances and mixtures (CLP). Published 2008. Accessed November 17, 2025. https://osha.europa.eu/en/legislation/directives/regulation-ec-no-1272-2008-classification-labelling-and-packaging-of-substances-and-mixtures.

Carcinogenicity Risk Assessment of Agrochemicals and Pharmaceuticals

Abstract

Keywords

Get full access to this article

References